Your browser doesn't support javascript.
loading
A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.
Wen, Patrick Y; Reardon, David A; Armstrong, Terri S; Phuphanich, Surasak; Aiken, Robert D; Landolfi, Joseph C; Curry, William T; Zhu, Jay-Jiguang; Glantz, Michael; Peereboom, David M; Markert, James M; LaRocca, Renato; O'Rourke, Donald M; Fink, Karen; Kim, Lyndon; Gruber, Michael; Lesser, Glenn J; Pan, Edward; Kesari, Santosh; Muzikansky, Alona; Pinilla, Clemencia; Santos, Radleigh G; Yu, John S.
Afiliação
  • Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. pwen@partners.org.
  • Reardon DA; Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Armstrong TS; Neuro-Oncology Branch, NCI, Bethesda, Maryland.
  • Phuphanich S; Barrow Neurological Institute, Phoenix, Arizona.
  • Aiken RD; Rutgers-Cancer Institute of New Jersey, New Brunswick, New Jersey.
  • Landolfi JC; New Jersey Neuroscience Institute, Edison, New Jersey.
  • Curry WT; Massachusetts General Hospital, Boston, Massachusetts.
  • Zhu JJ; University of Texas Health Sciences Center at Houston (UTHealth), Houston, Texas.
  • Glantz M; Penn State Hershey Medical Center, Hershey, Pennsylvania.
  • Peereboom DM; Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
  • Markert JM; University of Alabama at Birmingham, Birmingham, Alabama.
  • LaRocca R; Norton Cancer Institute, Louisville, Kentucky.
  • O'Rourke DM; Raymond and Ruth Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Fink K; Baylor Scott and White Neuro-Oncology Associates, Dallas, Texas.
  • Kim L; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
  • Gruber M; New York University, New York, New York.
  • Lesser GJ; Wake Forest Baptist Medical Center, Winston-Salem, North Carolina.
  • Pan E; University of Texas, Southwest Medical Center, Dallas, Texas.
  • Kesari S; John Wayne Cancer Institute and Pacific Neuroscience Institute, Santa Monica, California.
  • Muzikansky A; Alona Muzikansky, Massachusetts General Hospital, Boston, Massachusetts.
  • Pinilla C; Torrey Pines Institute for Molecular Studies, Port St. Lucie, Florida.
  • Santos RG; Torrey Pines Institute for Molecular Studies, Port St. Lucie, Florida.
  • Yu JS; Cedars-Sinai Medical Center, Los Angeles, California.
Clin Cancer Res ; 25(19): 5799-5807, 2019 10 01.
Article em En | MEDLINE | ID: mdl-31320597
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Neoplasias Encefálicas / Glioblastoma / Vacinas Anticâncer / Temozolomida Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Dendríticas / Neoplasias Encefálicas / Glioblastoma / Vacinas Anticâncer / Temozolomida Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article